SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential cannabis rescheduling, possibly driven by comments from President Trump, generating significant buzz in the cannabis sector. Community members are actively discussing potential short squeezes and the possibility of the stock reaching much higher valuations. The enthusiasm also stems from potential catalysts that could reshape the industry.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave's stock is facing downward pressure, sparking concerns among investors about its financial health and the broader AI infrastructure sector. Community discussions revolve around insider selling, construction delays, and debt levels, contributing to bearish sentiment despite the company's substantial backlog and long-term potential in AI. Some traders are looking for potential bounces and short-term opportunities, while others remain long-term bulls, citing the company's importance to the AI industry and potential for future growth.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent de-SPAC status and resulting momentum, with traders actively discussing its potential for a short squeeze given the high cost to borrow and low float. The community is focused on removing stop losses and setting high limit orders, anticipating a rally similar to SMX. Bullish sentiment is high as traders encourage each other to hold strong and combat perceived short attacks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock approaches its all-time high, driven by optimism around robotaxi advancements and analyst upgrades. Community discussions highlight the potential for a continued rally, while some traders express caution, citing valuation concerns and the possibility of a pullback. Bullish sentiment prevails, with many anticipating a further price increase.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial ($RILY) is trending as traders discuss a potential balance-sheet relief rally and possible short squeeze, with community members highlighting the stock's high short interest and low float. Some are pointing to a potential takeover, while others are focused on a specific catalyst related to Mainz Biomed distribution. The community is also discussing the impact of profitability filings on the stock's future performance.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users highlight its strong community and compare it to Bitcoin, emphasizing a culture-focused approach. Discussions revolve around its roots on the Solana blockchain and the potential for growth within the cannabis industry. The community uses terms like "WAGMI" and encourages others to join their X community.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Despite strong fundamentals and expansion news, Luckin Coffee is trending down, frustrating investors. The community is debating whether the recent price action is due to manipulation, large shareholders selling off, or broader market concerns. Some are hopeful for a bounce or relisting catalyst, while others express doubts about management and the company's communication.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amidst mixed sentiment, with community members debating the stock's future and short selling opportunities. Some express concerns over the company's financial performance and leadership, while others highlight positive aspects like the quality of Lucid's vehicles and potential for a short squeeze. Discussions also include comparisons to Chinese EV manufacturers and speculation about potential partnerships or acquisitions.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's stock is trending due to a softer-than-expected 2026 outlook, with community chatter focusing on declining COVID-19 product sales and upcoming patent expirations; some investors are expressing frustration with management while others see a buying opportunity based on underlying fundamentals and dividend yield. Discussions include analyst target prices, potential M&A activity, and the impact of the CEO's performance.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv is trending following analyst target price upgrades and strong earnings, with key drivers including AI-related data center demand and significant order growth. The community is closely watching price movements, particularly resistance levels, and discussing the potential for continued growth and a possible inclusion in the S&P 500. There's also debate around whether the AI sector is in a bubble.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Average Rating of "Hold" from Analysts

Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are covering the stock, Marketbeat.com reports...

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points PR Newswire VANCOUVER, BC, Dec...

Equities Analysts Issue Forecasts for TCRX FY2025 Earnings

TScan Therapeutics, Inc. (NASDAQ:TCRX - Free Report) - Equities researchers at HC Wainwright raised their FY2025 EPS estimates for TScan Therapeutics in a research note issued on Thursday, November...

Wedbush Reduces Earnings Estimates for TScan Therapeutics

TScan Therapeutics, Inc. (NASDAQ:TCRX - Free Report) - Investment analysts at Wedbush dropped their FY2025 EPS estimates for TScan Therapeutics in a research note issued to investors on Wednesday...

TScan Therapeutics (NASDAQ:TCRX) Downgraded by Morgan Stanley to "Equal Weight"

Morgan Stanley cut shares of TScan Therapeutics from an "overweight" rating to an "equal weight" rating in a research note on Friday...

HC Wainwright Has Lowered Expectations for TScan Therapeutics (NASDAQ:TCRX) Stock Price

HC Wainwright reduced their price objective on shares of TScan Therapeutics from $10.00 to $7.00 and set a "buy" rating for the company in a research note on Thursday...

TScan Therapeutics (NASDAQ:TCRX) Issues Quarterly Earnings Results, Beats Estimates By $0.07 EPS

TScan Therapeutics (NASDAQ:TCRX - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of...

TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Lags Revenue Estimates

TScan Therapeutics (TCRX) delivered earnings and revenue surprises of +20.00% and -21.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

TScan Therapeutics, Inc. (NASDAQ:TCRX) Given Consensus Recommendation of "Moderate Buy" by Analysts

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven analysts that are currently covering the firm, MarketBeat Ratings...

Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +60.80% and +50.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

Tscan Therapeutics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

TCRX
Tscan Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TCRX News

TCRXTscan Therapeutics Inc